Video & Transcript Research : 'hormone therapy'
Page 10 of 179
OK
Oklahoma 2026 Regular Session
Health and Human Services REVISED Mar 2nd, 2026
Health and Human Services
Transcript Highlights:
- They go into the care and therapy environment of one of our RCFs, our residential care facilities, and
- However, 20 years of therapy, treatment, and necessary service plans have allowed this person to go off
- So are they going to have someone giving follow-up, directly observed therapy, something to ensure that
- was whether, after release, individuals would have someone providing follow-up or directly observed therapy
- licensing provisions, background check provisions required for champion athletic trainer and occupational therapy
Bills:
SB1328, SB1380, SB1436, SB1558, SB1572, SB1651, SB1805, SB1831, SB1836, SB2014, SB2023, SB2044, SB2179, SB933
Keywords:
parents' rights, healthcare consent, minors, medical records, protection, legal guardianship, Medicaid, Oklahoma Health Care Authority, eligibility verification, death records, Death Master File, vital statistics, disenrollment, recoupment, improper payments, benefits integrity, public assistance, income verification, residency verification, incarceration status
Summary:
The Health and Human Services Committee met to consider a series of Senate bills, beginning with SB 2014, which would allow ivermectin to be sold over the counter with FDA approval. After questions about whether a prescription would still be required and how FDA guidance would affect the law, the bill passed 9-3. SB 1805, as amended, barred detention and youth facilities from using temporary agencies or contracting organizations for staffing; the author said the change was intended to address transparency and records issues in a related lawsuit. That bill passed 12-0. SB 2044, also amended, clarified chiropractic-related language regarding serum and multiple vitamins; members discussed whether the bill changed scope of practice, and it passed 10-2.
The committee then approved SB 1836, which requires a board-approved mental health screener during routine annual primary care visits. The author said it was meant to normalize mental health screening and noted an updated fiscal impact estimate of $284,000 to $560,000; some members raised concerns about mandates and cost, but the bill passed 8-4. SB 1380 would require the Oklahoma Health Care Authority to verify Medicaid eligibility against death records and conduct monthly death-record checks for enrollees; after questions about current practice, costs, and recoupment from deceased enrollees, the author requested title be stricken, and the bill passed 10-2. SB 2179, dealing with not-guilty-by-reason-of-mental-illness cases, adds staff accompaniment for therapeutic visits, requires structured violence-risk assessments before discharge or conditional release, and adds drug screening when substance-use monitoring is ordered; Department of Mental Health staff testified about treatment planning and monitoring, and the bill passed 11-1.
Later, the committee passed SB 1436, which requires families to be informed of their right to certification after fetal death or miscarriage, and SB 1558, which clarifies that older youth in OJA custody may be placed in Level E group homes. SB 933, the “Right to Try for Individualized Treatment Act,” passed 11-0 and would allow certain terminally ill patients to seek individualized investigational treatments after informed consent. SB 1651, an Oklahoma Medical Board cleanup bill covering several licensed professions, also passed 11-0. Finally, SB 1328 modernizes parental access to minor medical records with safeguards for abuse situations, and SB 1572 removes the DHS and OJA directors from the OCCY board; both passed 11-0. The committee adjourned after noting a possible interim meeting for a Tier 1 nomination.
OK
Oklahoma 2026 Regular Session
Public Health REVISION 2- HB1912 - Added - Part 2 Feb 18th, 2026 at 10:10 am
Public Health
Bills:
HB4336, HB1818, HB3194, HB3538, HB3682, HB3762, HB3793, HB3930, HB3931, HB3934, HB4124, HB4200, HB4410, HB4457, HB4473, HB3884, HB1912
Keywords:
interventional pain management, pain management clinic, chronic pain, acute pain, spinal injections, epidural steroid injection, peripheral nerve block, nerve ablation, spinal cord stimulator, intrathecal infusion pump, endoscopic diskectomy, fluoroscopy, physician supervision, allopathic physician, osteopathic physician, CRNA, certified registered nurse anesthetist, nurse anesthetist, freestanding pain management facility, medical licensure
OK
Bills:
HB4336, HB1818, HB3194, HB3538, HB3682, HB3762, HB3793, HB3930, HB3931, HB3934, HB4124, HB4200, HB4410, HB4457, HB4473, HB3884, HB1912
Keywords:
interventional pain management, pain management clinic, chronic pain, acute pain, spinal injections, epidural steroid injection, peripheral nerve block, nerve ablation, spinal cord stimulator, intrathecal infusion pump, endoscopic diskectomy, fluoroscopy, physician supervision, allopathic physician, osteopathic physician, CRNA, certified registered nurse anesthetist, nurse anesthetist, freestanding pain management facility, medical licensure
NM
New Mexico 2026 Regular Session
House - Chamber Meeting Jan 28th, 2026 at 11:02 am
New Mexico House Floor Meeting
Transcript Highlights:
- This is a ditto with occupational therapy. Ditto. No debate. Gentlelady, close. Mr.
Keywords:
nurses, health care workers, healthcare workers, frontline workers, hospital staff, clinicians, allied health professionals, support staff, public health, workforce shortage, nursing shortage, safe staffing, patient safety, rural health care, frontier communities, behavioral health, mental health, substance use disorder, substance abuse, health care memorial
FL
Transcript Highlights:
- They've been around; they're naturally occurring hormones.
- To develop tools, whether it be therapies or breeding, toward that ultimate tolerant tree.
- way, whether it's replanting, resetting, or using existing trees to try new and novel therapies.
- They're looking for more therapies. They don't have the capital. We've gotten more and more.
- They're looking for more therapies. They don't have the capital.
Summary:
The Senate Committee on Agriculture heard an update on the Florida citrus industry from Matt Joyner of Florida Citrus Mutual and Shannon Shepp of the Department of Citrus. Both described the industry’s steep decline over the past two decades due to citrus greening (HLB), hurricanes, freezes, and aging groves, but emphasized ongoing recovery efforts through research, replanting, and new therapies. They highlighted promising tools such as plant growth regulators, protective screens and covers, direct oxytetracycline application, CRISPR-based breeding, and the CRAFT program, which has expanded to more than 10,000 acres of solid-set plantings and over 20,000 acres including resets. Members discussed disaster relief, property tax pressures, grower participation, and the need for assessment relief and other state support. No votes were taken on the citrus presentation.
Shepp also outlined the Department of Citrus’s marketing and research role, noting strong consumer demand for Florida orange juice, global advertising efforts, and clinical research tied to health messaging. She said the industry remains a major economic contributor, with thousands of jobs and billions in economic impact, and that the department is working to maintain demand while growers replant and reset groves. Senators asked about the CRAFT program, new grower participation, and how advertising and state policy could help sustain the industry.
The committee then received a performance review of the Opa-locka Soil and Water Conservation Districts from David Jahossky of Malden and Jenkins. The review found wide variation among the 49 districts studied, with many lacking recurring revenue, staffing, proper meeting notices, records retention, formal performance goals, and timely financial reports. The report identified nearly 400 recommendations and noted that some districts had already dissolved or were considering dissolution. Senators questioned whether the districts were duplicative of other agencies and whether they still served a useful purpose; the presenter said there was overlap and collaboration but no duplication. A public commenter from Jefferson County argued that local boards still provide trusted, community-based support for producers and help connect them to cost-share and best management practice programs. The chair indicated the review would inform possible legislation to improve or restructure the districts, and the committee adjourned without taking a vote.
AZ
Transcript Highlights:
- Madam Chair, members, House Bill 2730 continues the Arizona Board of Occupational Therapy Examiners for
- , to see how many drugs it may apply to and how many times drugs with prior authorization or step therapy
- quantify the amount and the cost of folks that get addicted to opioid treatment if these non-opioid therapies
- language clarifying what prescription drugs are disallowed from using prior authorization and step therapy
- language clarifying what prescription drugs are disallowed from using prior authorization and step therapy
Keywords:
nursing board, regulatory actions, disciplinary actions, expungement, healthcare professionalism, controlled substances, prescription monitoring, opioid crisis, healthcare regulations, patient safety, prescription drugs, opioids, healthcare, pain management, utilization controls, AHCCCS, Department of Economic Security, social services, welfare programs, vocational rehabilitation
NH
New Hampshire 2026 Regular Session
House Children and Family Law (02/10/2026)
Children and Family Law
Transcript Highlights:
- Um, conversion therapy also is currently outlawed in New Hampshire.
- ><c> um</c><03:06:08.880><c> currently</c> conversion therapy also is um currently conversion therapy
- </c> therapy because that too is outlawed. therapy because that too is outlawed.
- </c><03:41:43.279><c> and</c> you started taking these hormones and you started taking these hormones
- Here in New Hampshire, conversion therapy is illegal.
AZ
Transcript Highlights:
- And so if the parents of a minor child are deciding that they should use hormones, then that is up to
- regulating gender transition procedures, but the treatments referenced here, puberty blockers and hormone
- therapy, are medications that are already used in pediatric medicine for other conditions.
- therapy, are medications that are already used in pediatric medicine for other conditions.
- In my opinion, you are allowing a physician in some cases to do a mastectomy or bring hormones into a
AZ
Transcript Highlights:
- Procedures, including puberty blockers, cross-sex hormones, and surgeries.
- If that same person detransitioned starts taking testosterone, there's no liability for that hormone
- replacement therapy or surgeries, etc., whether you are transitioning or detransitioning.
- Same hormone treatments, you would, that doctor would not be liable.
- Oh, that's somebody who relies on hormones right now because of the transition in my body.
CA
Transcript Highlights:
- Some examples include methyl and propyl parabens, both hormone disruptors, and propyl paraben has been
- Methyl and propyl parabens, both hormone disruptors, and propyl paraben has been shown to accelerate
- Admittedly, as someone who prioritizes going to therapy every week with an LCSW who I can identify with
- And if this research leads to positive outcomes, these therapies may become available through the VA
- therapy because of the laws in this country only.
NH
Transcript Highlights:
- But the studies show that after 12 months of hormone therapy, there is no competitive advantage.
- therapy.
- I'm asking if the study looked into that, cuz your testimony was after 12 months of hormone treatment
- I think he's referenced a study, only the reverse, but it suggested that after 12 months of hormone therapy
- therapy.
NH
Transcript Highlights:
- </c> condition treated with stem cell therapy condition treated with stem cell therapy pursuant<03:27
- </c> therapies. Can you expand upon this? therapies. Can you expand upon this?
- </c> they want to provide the therapies. they want to provide the therapies.
- </c> with access to life-changing therapies with access to life-changing therapies under<04:07:33.760
- </c><04:09:19.279><c> way</c> access to life-changing therapies way access to life-changing therapies
NH
New Hampshire 2026 Regular Session
House Commerce and Consumer Affairs (04/16/2026)
Commerce and Consumer Affairs
Transcript Highlights:
- </c> of therapies. of therapies.
- therapies and conventional therapies. therapies. therapies.
- therapy, those therapy, um occupational therapy, those kinds<03:35:15.680><c> of</c><03:35:15.800><c
- </c> in for physical therapy. in for physical therapy.
- 22.560><c> physical</c><03:56:22.920><c> therapy</c> physical therapy, but physical therapy physical
Summary:
The committee held a public hearing on Senate Bill 562, which would create a home damage mitigation and resilience grant program aimed at helping homeowners make property improvements that could reduce insurance costs and non-renewals. Commissioner DJ Bettencourt of the New Hampshire Insurance Department explained that the program is modeled in part on Alabama’s safer homes program, but tailored for New Hampshire hazards such as floods, microbursts, heavy snow, ice, and falling trees. He said the grants would be limited to primary residences, subject to a means test, capped at $10,000, and intended to help homeowners make targeted improvements such as roof fortification or tree removal that could improve underwriting outcomes and lead to premium discounts.
Bettencourt said the program would not use state taxpayer funds and would instead rely on philanthropic donations, possible federal or regional housing-bank funding, and other outside sources. He said the department would not need new staff, and that a current position could be reconfigured to help administer the program part-time. Committee members asked about the funding language, the meaning of “loans” in the bill, whether there were any other states using a similar no-state-funds model, and how many homeowners could be helped. Bettencourt said Rhode Island and Connecticut were moving forward in a similar way, and that the number of beneficiaries would depend on how much money is raised.
Members also questioned how the grant program would actually lower premiums, whether savings would apply only to participants or more broadly, and how the IBHS evaluation process would work. Bettencourt and department staff said the direct benefit would be to the homeowner whose property is improved, though neighbors could also benefit in some cases. They explained that IBHS is a building-safety organization that certifies contractors and inspectors and that its standards can qualify homes for insurer discounts. Questions were also raised about confidentiality provisions, first-come-first-served grant awards, rollover of unused applications, and possible tax treatment of donations. The sponsor said those details would be addressed through rulemaking or existing tax rules, and no vote was taken during the hearing.
NH
New Hampshire 2026 Regular Session
House Commerce and Consumer Affairs (04/16/2026)
Commerce and Consumer Affairs
Transcript Highlights:
- therapies and conventional therapies. therapies. therapies.
- Um, I would liken it to physical therapy in your home or physical therapy, occupational therapy, those
- Um, I would liken it to physical therapy in your home or physical therapy, occupational therapy, those
- Um, I would liken it to physical therapy in your home or physical therapy, occupational therapy, those
- </c> in for physical therapy. in for physical therapy.
NH
New Hampshire 2026 Regular Session
Commission to Study Costs of Special Education (06/02/2026)
Transcript Highlights:
- They work along the same rubric when it comes to billing for therapies.
- ><c> that</c><03:50:20.080><c> therapy</c><03:50:20.479><c> plan.
- </c><03:50:21.359><c> As</c> they were working that therapy plan.
- As they were working that therapy plan.
- So, and don't get billing for therapies.
Summary:
The commission met to approve the May 18, 2026 minutes and then focused on how SB 57’s special education cost study should inform HB 1099, which creates a separate study committee on residential placements and related education costs. Members discussed sending the commission’s minutes and findings to that new committee, noting the short timeline for its work and the need to be specific about unresolved issues so the new group does not duplicate the same questions.
A major topic was the cost and responsibility for students placed at Spalding and similar residential programs, especially transportation and whether costs are paid through the Department of Education’s episode-of-treatment (EOT) fund, local districts, DHS, or Medicaid. Staff explained that for students with disabilities, EOT funds cover special education and transportation costs tied to the placement, while students without disabilities are handled through DHS care-management and best-interest meetings. Members raised concerns about whether some students at Spalding are receiving no schooling, whether transportation costs are substantial, and whether Medicaid reimbursement could offset some expenses.
The commission also discussed confusion over district responsibility when students placed in residential programs attend school in another district, using Winnisquam as an example. Several members said the receiving district was not notified that DHHS-approved programs could bring in additional students and costs, and they suggested DHHS or its care-management entity should notify both the district of residence and the receiving district when a program is approved. The group agreed this notification issue, along with transportation funding, privacy concerns in Medicaid-to-schools billing, and the distinction between special education placements, EOT placements, and other voluntary residential placements, should be passed to the HB 1099 study committee for further work.
KY
Transcript Highlights:
- </c><01:47:56.000><c> that</c> access investigational therapies that access investigational therapies
- therapies, genomic therapies, cell therapies, genomic medicine,<01:51:36.800><c> and</c><01:51:37.040
- and HER2 therapies.
- and her h2 upon for her targeted hormone and her h2 therapies. therapies. therapies.
- Who pays for these therapies?
CA
California 2025-2026 Regular Session
Assembly Appropriations Committee Aug 29th, 2025
Appropriations
CA
Transcript Highlights:
- to balance the competing needs of the industry it regulates, patients' desire for access to drug therapies
- Pharmacists are medication experts who optimize drug therapy to ensure safety and efficacy.
- Naturopathic doctors, or NDs, are highly trained in IV therapy.
- We're actually required to have additional training to... ...highly trained in IV therapy.
- I have significant reservations about the Board of Pharmacy regulating IV therapy.
Summary:
The joint Assembly and Senate business committees held a sunset review hearing on the California State Board of Pharmacy, with board leadership describing the board’s consumer-protection role and its priorities around access, enforcement, and updating pharmacy law. The board emphasized a proposed shift toward a standard-of-care model for pharmacists, arguing it would reduce rigid protocol requirements and improve access to services such as HIV PrEP/PEP, contraception, and naloxone. Board representatives also discussed pharmacy deserts, possible fee waivers for pharmacies in underserved areas, concerns about payer practices contributing to closures, continuing education audits, and a request to restore more flexibility in licensure decisions and probationary monitoring for applicants with certain criminal histories.
A major focus of the hearing was the board’s ongoing compounding regulations, especially the treatment of sterile versus nonsterile compounding and substances such as glutathione and methylcobalamin. The board said the proposal was not a ban on those substances and described the rulemaking as grounded in federal law, USP standards, and public comment, noting the process had gone through multiple modified texts and hearings. Testimony from stakeholders was sharply divided: pharmacists, veterinarians, firefighters, naturopathic doctors, and patient advocates warned the rules were restricting access to compounded medications and harming patients and first responders, while the California Medical Association, psychiatric physicians, and PhRMA raised concerns that the board’s proposals could expand pharmacist authority beyond training, affect physician practice, or create safety risks. Other public comments addressed pharmacy technician ratios, remote processing, flavoring medications, hospital-specific regulation, budget and enforcement transparency, and whether the board should add members with community compounding or pharmacy technician expertise.
Committee members also asked about the board’s oversight priorities and the rationale for its standard-of-care proposal. Board staff explained that consumer protection includes education, licensing, policy, and enforcement, with the highest-priority enforcement cases being those posing imminent public harm. After public testimony concluded, the chairs thanked participants and adjourned the sunset review hearing, announcing an immediate transition to the joint informational hearing on the Department of Cannabis Control.
AZ
Transcript Highlights:
- And so if the parents of a minor child are deciding that they should use hormones, then that is up to
- regulating gender transition procedures, but the treatments referenced here, puberty blockers and hormone
- therapy, are medications that are already used in pediatric medicine for other conditions.
- regulating gender transition procedures, but the treatments referenced here, puberty blockers and hormone
- therapy, are medications that are already used in pediatric medicine for other conditions.
Summary:
The House convened with prayer, the Pledge of Allegiance, attendance, guest introductions, and several ceremonial proclamations, including recognition of Dr. Joseph Torkelson for his service in pediatric oncology and military medicine. Members also introduced guests connected to Arizona Bleeding Disorders, charter schools, and a suicide-prevention effort tied to HB 2665 (“Cade’s Law”). The chamber then moved through multiple Committee of the Whole calendars, considering a large number of bills and resolutions.
On the first calendar, the House gave do pass recommendations, mostly as amended, to HB 2117, 2744, 2751, 2917, 2939, 2957, 2970, and HCR 2038. The amendments addressed topics such as natural resource conservation district boundaries, manufacturing and jobs, Real ID/non-Real ID data privacy, and Colorado River conservation and tribal/community representation. The House then adopted the Committee of the Whole report and sent the measures for engrossing; a later motion to amend the report to include the defeated Villegas amendment on HB 2667 failed by roll call vote, 22-32 with 6 not voting.
In the next calendars, the House advanced HB 2015, 2129, 2327, 2439, 2533, 2667, 2793, 2873, HCR 2044, and others, with several floor or committee amendments adopted. Debate focused on homelessness coordination in HB 2533, homebuyer assistance and corporate ownership concerns in HB 2667, annexation and local control in HB 2793, and a proposed constitutional referral in HCR 2044 aimed at closing loopholes for discrimination in public programs. The House also considered HB 2044 and HB 2076 in the Judiciary calendar, with debate over the scope of a homicide-disposal statute in HB 2044 and school safety/teacher firearms issues in HB 2076; both bills advanced as amended.
The final calendar covered natural resources, energy, and water bills. The House advanced HB 2014, 2055, 2145, 2185, 2267, 2340, 2428, 2696, 2798, 2955, 2975, and 2986, with amendments on drought definitions, emissions permitting, mineral district mapping, and environmental enforcement authority. HB 2267 drew the sharpest debate, with opponents arguing it would hinder solar and wind development and supporters arguing for diversification toward coal, gas, and nuclear; after a division vote, the bill still received a do pass recommendation. The session concluded with the Committee of the Whole rising and reporting, and the House adopting the report and assigning the measures accordingly.
TX
Transcript Highlights:
- They don't respond to therapies like L-DOBER. cinema.
- But it's also other. factors, hormonal factors, genetic factors.
- We have different chromosomes, different hormones. different organs, not surprisingly very different
- Alzheimer's, now they're attempting to use these monoclonal therapies to prevent the disease from ever
- After just over two months of therapy, I now have hope for my future. future and can cope with my loved